Laird Norton Wetherby Wealth Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-15,839
Closed -$239K 923
2022
Q1
$239K Buy
+15,839
New +$239K 0.01% 789